These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6966821)

  • 21. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus.
    Clough JD; Frank SA; Calabrese LH
    Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.
    Jenks SA; Wei C; Bugrovsky R; Hill A; Wang X; Rossi FM; Cashman K; Woodruff MC; Aspey LD; Lim SS; Bao G; Drenkard C; Sanz I
    Ann Rheum Dis; 2021 Sep; 80(9):1190-1200. PubMed ID: 34083207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus.
    Czyzyk J; Fernsten P; Shaw M; Winfield JB
    Arthritis Rheum; 1996 Apr; 39(4):592-9. PubMed ID: 8630107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte subsets in patients with systemic lupus erythematosus.
    DeHoratius RJ
    Arthritis Rheum; 1982 Jul; 25(7):828-32. PubMed ID: 7049186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-daunorubicin complexes specifically suppress in vitro spontaneous anti-DNA antibody production in lymphocytes of patients with systemic lupus erythematosus.
    Takeuchi T; Koide J; Hosono O; Amano K; Homma M; Masuho Y; Morimoto C; Takano M; Abe T
    Arthritis Rheum; 1986 Oct; 29(10):1216-22. PubMed ID: 3490263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphocytic and lymphocytoactive components in the etiopathogenic mechanisms of systemic lupus erythematosus. An analysis of the literature].
    Angela GC; Cavallo G; Fiorio C
    G Batteriol Virol Immunol; 1983; 76(1-6):25-42. PubMed ID: 6237017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic observations on 9 sets of twins either concordant or discordant for SLE.
    Block SR; Lockshin MD; Winfield JB; Weksler ME; Imamura M; Winchester RJ; Mellors RC; Christian CL
    Arthritis Rheum; 1976; 19(3):545-54. PubMed ID: 132937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.
    Yamada A; Winfield JB
    J Clin Invest; 1984 Dec; 74(6):1948-60. PubMed ID: 6210306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional differences of anti-T-cell antibody in patients with systemic lupus erythematosus and ulcerative colitis.
    Abe T; Morimoto C; Toguchi T; Kiyotaki M; Takeuchi T; Koide J; Asakura H; Tsuchiya M; Homma M
    Scand J Immunol; 1983 Dec; 18(6):521-30. PubMed ID: 6229872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals.
    Gutiérrez MA; Molina JF; Jara LJ; García C; Gutiérrez-Ureña S; Cuéllar ML; Gharavi A; Espinoza LR
    Int Arch Allergy Immunol; 1996 Mar; 109(3):229-35. PubMed ID: 8620091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies.
    Kikuchi Y; Koarada S; Tada Y; Ushiyama O; Morito F; Suzuki N; Ohta A; Miyake K; Kimoto M; Horiuchi T; Nagasawa K
    Arthritis Rheum; 2002 Dec; 46(12):3259-65. PubMed ID: 12483730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production.
    Takeno M; Nagafuchi H; Kaneko S; Wakisaka S; Oneda K; Takeba Y; Yamashita N; Suzuki N; Kaneoka H; Sakane T
    J Immunol; 1997 Apr; 158(7):3529-38. PubMed ID: 9120315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.